Nicotinamide N‐methyltransferase sustains a core epigenetic program that promotes metastatic colonization in breast cancer
The EMBO Journal · 2023
DOI: 10.15252/embj.2022112559 ↗Kurz gefasst
Fachartikel in der Zeitschrift The EMBO Journal, 2023. Verfasst von Joana Pinto Couto und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Nicotinamide N-Methyltransferase, Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Swiss National Science Foundation, European Research Council, H2020 Marie Skłodowska-Curie Actions.
Abstract (Originalsprache)
Metastatic colonization of distant organs accounts for over 90% of deaths related to solid cancers, yet the molecular determinants of metastasis remain poorly understood. Here, we unveil a mechanism of colonization in the aggressive basal-like subtype of breast cancer that is driven by the NAD+ metabolic enzyme nicotinamide N-methyltransferase (NNMT). We demonstrate that NNMT imprints a basal genetic program into cancer cells, enhancing their plasticity. In line, NNMT expression is associated with poor clinical outcomes in patients with breast cancer. Accordingly, ablation of NNMT dramatically suppresses metastasis formation in pre-clinical mouse models. Mechanistically, NNMT depletion results in a methyl overflow that increases histone H3K9 trimethylation (H3K9me3) and DNA methylation at the promoters of PR/SET Domain-5 (PRDM5) and extracellular matrix-related genes. PRDM5 emerged in this study as a pro-metastatic gene acting via induction of cancer-cell intrinsic transcription of collagens. Depletion of PRDM5 in tumor cells decreases COL1A1 deposition and impairs metastatic colonization of the lungs. These findings reveal a critical activity of the NNMT-PRDM5-COL1A1 axis for cancer cell plasticity and metastasis in basal-like breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
- Department of Surgery, University Hospital Basel, Basel, Switzerland.
- Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
- Proteomics Core Facility, Biozentrum, University of Basel, Basel, Switzerland.
- Swiss Institute of Bioinformatics, Basel, Switzerland.
- Computational and Translational Pathology Group, Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zürich, Switzerland.
ORCID-Profile: Milica Vulin, Charly Jehanno, Marie-May Coissieux, Alexander Schmidt, Robert Ivanek, Konstantin Bräutigam, Jorge Gómez-Miragaya, Zsuzsanna Varga, Viktor H Koelzer, Kirsten D Mertz, Mohamed Bentires-Alj
Förderung
- Swiss National Science Foundation
- European Research Council
- H2020 Marie Skłodowska-Curie Actions
- European Molecular Biology Organization
- Krebsliga Schweiz
- Promedica Stiftung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Novartis
Zitieren
APA
Couto, J. P., Vulin, M., Jehanno, C., Coissieux, M. M., Hamelin, B., Schmidt, A., Ivanek, R., Sethi, A., Bräutigam, K., Frei, A. L., Hager, C., Manivannan, M., Gómez-Miragaya, J., Obradović, M. M., Varga, Z., Koelzer, V. H., Mertz, K. D., & Bentires-Alj, M. (2023). Nicotinamide N‐methyltransferase sustains a core epigenetic program that promotes metastatic colonization in breast cancer. The EMBO Journal. https://doi.org/10.15252/embj.2022112559
Vancouver
Couto JP, Vulin M, Jehanno C, Coissieux MM, Hamelin B, Schmidt A, et al. Nicotinamide N‐methyltransferase sustains a core epigenetic program that promotes metastatic colonization in breast cancer. The EMBO Journal. 2023. doi:10.15252/embj.2022112559
BibTeX
@article{Couto2023,
author = {Couto, Joana Pinto and Vulin, Milica and Jehanno, Charly and Coissieux, Marie-May and Hamelin, Baptiste and Schmidt, Alexander and Ivanek, Robert and Sethi, Atul and Bräutigam, Konstantin and Frei, Anja L and Hager, Carolina and Manivannan, Madhuri and Gómez-Miragaya, Jorge and Obradović, Milan Ms and Varga, Zsuzsanna and Koelzer, Viktor H and Mertz, Kirsten D and Bentires-Alj, Mohamed},
title = {Nicotinamide N‐methyltransferase sustains a core epigenetic program that promotes metastatic colonization in breast cancer},
journal = {The EMBO Journal},
year = {2023},
doi = {10.15252/embj.2022112559}
}
EUVIMED